CYP1A1 and CYP2E1 genotypes and risk of esophageal squamous cell carcinoma in a high-incidence region, Kashmir

Tumor Biology

Volumn 35, Issue 6, 2014, Pages 5323-5330

  Bhat, Gulzar Ahmad ^a   Shah, Idrees Ayoub ^a   Makhdoomi, Muzamil Ashraf ^a   Iqbal, Beenish ^a   Rafiq, Rumaisa ^a   Nabi, Sumaiya ^a   Masood, Akbar ^a   Lone, Mohd Maqbool ^b   Dar, Nazir Ahmad ^a  

^a UNIVERSITY OF KASHMIR   (India)

^b SHER I KASHMIR INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

CYP1A1; CYP2E1; Esophageal squamous cell carcinoma; Interaction; Kashmir; Polymorphism; Smoking

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 2E1;

ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SMOKING;

AGED; CARCINOMA, SQUAMOUS CELL; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2E1; ESOPHAGEAL NEOPLASMS; GENOTYPE; HUMANS; INCIDENCE; INDIA; MIDDLE AGED; RISK;

EID: 84904743972     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1694-6     Document Type: Article

References (47)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74-108. (Pubitemid 40372904)
2. Wang LD, Zhou Q, Feng CW, Liu B, Qi YJ, Zhang YR, et al. Intervention and follow-up on human esophageal precancerous lesions in Henan, northern China, a high-incidence area for esophageal cancer. Gan To Kagaku Ryoho. 2002;29 Suppl 1:159-72.
3. Jemal A, Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(8):1893-907. doi:10.1158/1055-9965.epi-10-0437
4. Reed PI, Johnston BJ. The changing incidence of oesophageal cancer. Endoscopy. 1993;25(9):606-8. doi:10.1055/s-2007-1010414. (Pubitemid 24002739)
5. Gholipour C, Shalchi RA, Abbasi M. A histopathological study of esophageal cancer on the western side of the Caspian littoral from 1994 to 2003. Dis Esophagus. 2008;21(4):322-7. doi:10.1111/j.1442-2050.2007.00776.x. (Pubitemid 351663448)
6. Dar NA, Bhat GA, Shah IA, Iqbal B, Makhdoomi MA, Nisar I, et al. Hookah smoking, nass chewing, and oesophageal squamous cell carcinoma in Kashmir, India. Br J Cancer. 2012;107(9):1618-23. doi:10.1038/bjc.2012.449.
7. Siddiqi MA, Tricker AR, Kumar R, Fazili Z, Preussmann R. Dietary sources of N-nitrosamines in a high-risk area for oesophageal cancer - Kashmir, India. IARC Sci Publ. 1991;105:210-3.
8. Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer J Int du Cancer. 2005;113(3):456-63. doi:10.1002/ijc.20616. (Pubitemid 40038715)
9. Turati F, Edefonti V, Bosetti C, Ferraroni M, Malvezzi M, Franceschi S, et al. Family history of cancer and the risk of cancer: a network of case-control studies. Ann Oncol. 2013. doi:10.1093/annonc/mdt280.
10. Bye H, Prescott NJ, Matejcic M, Rose E, Lewis CM, Parker MI, et al. Population-specific genetic associations with oesophageal squamous cell carcinoma in South Africa. Carcinogenesis. 2011;32(12):1855-61. doi:10.1093/carcin/bgr211.
11. Qin JM, Yang L, Chen B, Wang XM, Li F, Liao PH, et al. Interaction ofmethylenetetrahydrofolate reductase C677T, cytochrome P4502E1 polymorphism and environment factors in esophageal cancer in Kazakh population. World J Gastroenterol: WJG. 2008;14(45):6986-92.
12. Shi Y, Luo GJ, Zhang L, Shi J, Zhang DQ, Chen JM, et al. Interaction between alcohol consumption and CYP 2C19 gene polymorphism in relation to oesophageal squamous cell carcinoma. PloS one. 2012;7(9):e43412. doi:10.1371/journal.pone.0043412.
13. Tanaka F, Yamamoto K, Suzuki S, Inoue H, Tsurumaru M, Kajiyama Y, et al. Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles. Gut. 2010;59(11):1457-64. doi:10.1136/gut.2009.205724.
14. Boffetta P. Biomarkers in cancer epidemiology: an integrative approach. Carcinogenesis. 2010;31(1):121-6. doi:10.1093/carcin/bgp269.
15. Roshandel G, Semnani S, Malekzadeh R, Dawsey SM. Polycyclic aromatic hydrocarbons and esophageal squamous cell carcinoma. Arch Iran Med. 2012;15(11):713-22.
16. Zhuo XG, Watanabe S. Factor analysis of digestive cancer mortality and food consumption in 65 Chinese counties. J Epidemiol. 1999;9(4):275-84.
17. Hakami R, Mohtadinia J, Etemadi A, Kamangar F, Nemati M, Pourshams A, et al. Dietary intake of benzo(a)pyrene and risk of esophageal cancer in north of Iran. Nutr Cancer. 2008;60:216-21. (Pubitemid 351451279)
18. Kamangar FSP, Pourshams A, Malekzadeh R, Boffetta P, Roth MJ, et al. High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res. 2005;25:425-8.
19. Kawajiri K, Watanabe J, Hayashi S. Identification of allelic variants of the human CYP1A1 gene. Methods Enzymol. 1996;272:226-32.
20. Bergheim I, Wolfgarten E, Bollschweiler E, Holscher AH, Bode C, Parlesak A. Cytochrome P450 levels are altered in patients with esophageal squamous-cell carcinoma. World J Gastroenterol. 2007;13(7):997-1002. (Pubitemid 46510999)
21. Rasool MT, Lone MM, Wani ML, Afroz F, Zaffar S, Mohib-ul HM. Cancer in Kashmir, India: burden and pattern of disease. J Cancer Res Ther. 2012;8(2):243-6. doi:10.4103/0973-1482.98978.
22. Khuroo MS, Zargar SA, Mahajan R, Banday MA. High incidence of oesophageal and gastric cancer in Kashmir in a population with special personal and dietary habits. Gut. 1992;33(1):11-5.
23. Kumar R, Siddiqi M, Fazili Z, Wacker CD, Spiegelhalder B, Preussmann R. Effect of dietary nitrate on endogenous nitrosation of piperazine in humans. Cancer Lett. 1992;65(2):139-43.
24. Sambrook J, Russell D. Molecular cloning: a laboratory manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press; 2001.
25. Cascorbi I, Brockmoller J, Roots I. AC4887A polymorphismin exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Res. 1996;56(21):4965-9. (Pubitemid 26374436)
26. Hayashi S, Watanabe J, Kawajiri K. Genetic polymorphisms in the 5′-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem. 1991;110(4):559-65.
27. Godoy W, Albano RM, Moraes EG, Pinho PR, Nunes RA, Saito EH, et al. CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism. Carcinogenesis. 2002;23(4):611-6. (Pubitemid 34498499)
28. Murray GI, Shaw D, Weaver RJ, McKay JA, Ewen SW, Melvin WT, et al. Cytochrome P450 expression in oesophageal cancer. Gut. 1994;35(5):599-603. (Pubitemid 24163781)
29. Landi MT, Bertazzi PA, Shields PG, Clark G, Lucier GW, Garte SJ, et al. Association between CYP1A1 genotype, mRNA expression and enzymatic activity in humans. Pharmacogenetics. 1994;4(5):242-6. (Pubitemid 24337432)
30. Murata M, Watanabe M, Yamanaka M, Kubota Y, Ito H, Nagao M, et al. Genetic polymorphisms in cytochrome P450 (CYP) 1A1, CYP1A2, CYP2E1, glutathione S-transferase (GST) M1 and GSTT1 and susceptibility to prostate cancer in the Japanese population. Cancer Lett. 2001;165(2):171-7. (Pubitemid 32244174)
31. Rojas M, Cascorbi I, Alexandrov K, Kriek E, Auburtin G, Mayer L, et al. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism. Carcinogenesis. 2000;21(1):35-41. (Pubitemid 30064141)
32. Nakajima T, Wang RS, Nimura Y, Pin YM, He M, Vainio H, et al. Expression of cytochrome P450s and glutathione S-transferases in human esophagus with squamous-cell carcinomas. Carcinogenesis. 1996;17(7):1477-81. (Pubitemid 26242654)
33. Kiyohara C, Hirohata T, Inutsuka S. The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn J Cancer Res. 1996;87(1):18-24. (Pubitemid 26062844)
34. Gonzalez A, Ramirez V, Cuenca P, Sierra R. [Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility]. Rev Biol Trop. 2004;52(3):591-600.
35. Kim RB, Yamazaki H, Chiba K, O'Shea D, Mimura M, Guengerich FP, et al. In vivo and in vitro characterization of CYP2E1 activity in Japanese and Caucasians. J Pharmacol Exp Ther. 1996;279(1):4-11. (Pubitemid 27166886)
36. Lucas D, Menez C, Girre C, Berthou F, Bodenez P, Joannet I, et al. Cytochrome P450 2E1 genotype and chlorzoxazone metabolism in healthy and alcoholic Caucasian subjects. Pharmacogenetics. 1995;5(5):298-304.
37. Leng W-D, Zeng X-T, Chen Y-J, Duan X-L, Niu Y-M, Long R-P, et al. Cytochrome P450 2E1 RsaI/PstI polymorphism and risk of esophageal cancer: a meta-analysis of 17 case-control studies. Exp Ther Med. 2012;4(5):938-48.
38. Wu MT, Lee JM, Wu DC, Ho CK, Wang YT, Lee YC, et al. Genetic polymorphisms of cytochrome P4501A1 and oesophageal squamous-cell carcinoma in Taiwan. Br J Cancer. 2002;87(5):529-32. doi:10.1038/sj.bjc.6600499.
39. Liu R, Yin L-h, Yue-pu PU. Association of combined CYP2E1 gene polymorphism with the risk for esophageal squamous cell carcinoma in Huai'an population, China. Chin Med J. 2007;120(20):1797-802. (Pubitemid 350111086)
40. Morita S, Yano M, Shiozaki H, Tsujinaka T, Ebisui C, Morimoto T, et al. CYP1A1, CYP2E1 and GSTM1 polymorphisms are not associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer. 1997;71(2):192-5. (Pubitemid 27252989)
41. Danko IM, Chaschin NA. Association of CYP2E1 gene polymorphism with predisposition to cancer development. Exp Oncol. 2005;27(4):248-56. (Pubitemid 43139353)
42. Garte S. The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1. Carcinogenesis. 1998;19:1329-32. (Pubitemid 28409826)
43. Yuming NH, Yuan, Weidong L, Yongchu P, Ning G, Ning C. CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls. Med Oncol. 2011;28:182-7. doi:10.1007/s12032-010-9455-x.
44. Abnet CC, Wang Z, Song X, Hu N, Zhou FY, Freedman ND, et al. Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies. Human Mol Genet. 2012;21(9):2132-41. doi:10.1093/hmg/dds029.
45. Chen YZ, Cui XB, Hu JM, Zhang WJ, Li SG, Yang L, et al. Overexpression of PLCE1 in Kazakh esophageal squamous cell carcinoma: implications in cancer metastasis and aggressiveness. APMIS: Acta Pathol Microbiol Immunol Scand. 2013;121(10):908-18. doi:10.1111/apm.12095.
46. Duan F, Xie W, Cui L, Wang P, Song C, Qu H, et al. Novel functional variants locus in PLCE1 and susceptibility to esophageal squamous cell carcinoma: based on published genome-wide association studies in a central Chinese population. Cancer Epidemiol. 2013;37(5):647-52. doi:10.1016/j.canep. 2013.04.009.
47. Malik MA, Upadhyay R, Mittal RD, Zargar SA, Mittal B. Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors. Nutr Cancer. 2010;62(6):734-42. doi:10.1080/01635581003605904.